Skip to main content
ALLERGY THERAPEUTICS PLC logo

ALLERGY THERAPEUTICS PLC — Investor Relations & Filings

Ticker · AGY ISIN · GB00B02LCQ05 LEI · 213800PQ7AHK7KGVOE23 IL Manufacturing
Filings indexed 416 across all filing types
Latest filing 2021-07-14 Earnings Release
Country GB United Kingdom
Listing IL AGY

About ALLERGY THERAPEUTICS PLC

https://allergytherapeutics.com/

Allergy Therapeutics PLC is an immunology company focused on the research, development, diagnosis, and treatment of allergic disorders. The company specializes in creating therapies for allergy treatment and prevention, with a key focus on developing aluminum-free immunotherapies and allergy vaccines. These treatments aim to address the underlying cause of the allergy rather than merely managing symptoms. Leveraging its specialist expertise in immunology, the company strives to develop effective and convenient solutions to improve the quality of life for individuals with allergies.

Recent filings

Filing Released Lang Actions
Trading update for the year ended 30 June 2021
Earnings Release Classification · 100% confidence The document is a formal announcement released via RNS (RNS Number: 1436F) on July 14, 2021, titled 'Trading update for the year ended 30 June 2021'. It provides preliminary financial highlights (revenue expected at £84.3m, expenses lower than expected, record cash level) and operational updates (pipeline progress, product launches) for the fiscal year ending June 30, 2021. This content structure—a summary of key financial performance metrics before the full audited report—is characteristic of an Earnings Release (ER). It is not the full Annual Report (10-K) or a comprehensive Interim Report (IR), but rather the initial announcement of period results. FY 2021
2021-07-14 English
AGY to present key scientific findings at EAACI
Regulatory Filings Classification · 95% confidence The document is an announcement released via RNS (RNS Number : 5270E) on July 8, 2021. The content details that Allergy Therapeutics will be presenting scientific findings at the EAACI 2021 Congress and lists the specific posters and symposia scheduled. It explicitly states, 'No new material price sensitive information is expected to be disclosed at the EAACI Congress.' Furthermore, the footer indicates this information is provided by 'Reach, the non-regulatory press release distribution service of RNS,' and confirms it is of a 'non-regulatory nature.' Since this is an announcement about future scientific presentations and not the presentation material itself, nor a core financial report (like 10-K, ER, or IR), it fits best as a general regulatory announcement or news release that doesn't fit a more specific category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general, non-price sensitive, non-core financial announcement distributed via the RNS system, especially since it is explicitly marked as a 'Reach' (non-regulatory) release.
2021-07-08 English
Trading Update
Earnings Release Classification · 99% confidence The document is identified by the 'RNS Number' header and explicitly states, 'This information is provided by RNS, the news service of the London Stock Exchange.' The content is a 'pre-close trading update' for the year ended 30 June 2021, providing key financial highlights (operating profit, expenses, cash position) and future outlook. This format—a brief announcement summarizing performance ahead of a full report—is characteristic of an Earnings Release (ER). Although it is distributed via RNS, the primary content type is the earnings summary, not just a general regulatory notice or an announcement of a report (RPA). Since it contains specific financial performance metrics for a period, ER is the most accurate classification over the general RNS fallback. FY 2021
2021-06-24 English
Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the 'RNS Number' header and explicitly states it is provided by 'RNS, the news service of the London Stock Exchange'. The content announces the total number of voting rights following the issuance of new ordinary shares due to option exercises, citing the FCA's Disclosure Guidance and Transparency Rules (DTR 5.6.1). This type of mandatory, short-form regulatory update, especially when sourced directly from RNS, fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (10-K, IR), a management change (MANG), or a dividend notice (DIV). Given the context of RNS distribution and the nature of the announcement, RNS is the most appropriate classification.
2021-06-01 English
Second Price Monitoring Extn
Regulatory Filings Classification · 98% confidence The document is very short (1937 characters) and announces a 'Second Price Monitoring Extension' related to trading activity on the London Stock Exchange, identified by the 'RNS Number'. It explicitly states that the information is provided by RNS, the news service of the London Stock Exchange, and is approved by the Financial Conduct Authority (FCA). This is a general regulatory announcement concerning trading mechanics rather than a specific financial report (like 10-K, IR, or ER). Since it is a general regulatory announcement that doesn't fit the specific categories like DIRS, DIV, or CAP, the most appropriate fallback category is Regulatory Filings (RNS).
2021-05-10 English
Price Monitoring Extension
Regulatory Filings Classification · 99% confidence The document explicitly starts with 'RNS Number' and contains information about an extension to the 'Price Monitoring' auction call period for a security listed on the London Stock Exchange. It concludes by stating, 'This information is provided by RNS, the news service of the London Stock Exchange.' This clearly identifies the document as a general regulatory announcement disseminated via the RNS system, which aligns with the definition for Regulatory Filings (RNS). It is not a specific financial report, management change, or shareholder vote result.
2021-05-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.